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Abstract: Accurate division of cells into two daughters is a process that is vital to propagation of
life. Protein phosphorylation and selective degradation have emerged as two important mechanisms
safeguarding the delicate choreography of mitosis. Protein phosphatases catalyze dephosphorylation
of thousands of sites on proteins, steering the cells through establishment of the mitotic phase and exit
from it. A large E3 ubiquitin ligase, the anaphase-promoting complex/cyclosome (APC/C) becomes
active during latter stages of mitosis through G1 and marks hundreds of proteins for destruction.
Recent studies have revealed the complex interregulation between these two classes of enzymes.
In this review, we highlight the direct and indirect mechanisms by which phosphatases and the
APC/C mutually influence each other to ensure accurate spatiotemporal and orderly progression
through mitosis, with a particular focus on recent insights and conceptual advances.
Keywords: phosphatase; kinase; anaphase-promoting complex/cyclosome (APC/C); cyclin-dependent
kinase 1 (Cdk1); cyclin; mitosis; cell cycle; phosphorylation; ubiquitylation
1. Introduction
From the outset, the process of cell division might seem mired in extraordinary complexity.
Following a series of distinct steps, a eukaryotic cell is able to duplicate its genetic content and partition
it among its two daughters along with other organelles with remarkable precision. Decades of research
has sought to understand the molecular and physico-chemical underpinnings of the ‘cell division cycle’:
from DNA replication, transitory structures such as the mitotic spindle devoted to its distribution,
to control systems that monitor the fidelity of these processes. The realization that reversible protein
modifications such as phosphorylation and ubiquitylation are at the heart of the cell cycle engine has
demystified many of its aspects.
The primary focus of this review is to highlight the roles of two classes of protein modifying enzymes
that are central to accurate mitosis and the complex interplay between them: protein phosphatases
and the E3 ubiquitin ligase, anaphase-promoting complex/cyclosome (APC/C), with a focus on recent
advances. These two modifiers act in concert with numerous mitotic kinases to orchestrate various
events of mitosis.
1.1. Protein Phosphatases—Ubiquitous Enzymes that Regulate Cell Physiology and Division
The discovery of phosphatases, then called ‘prosthetic group’-removing or PR enzymes, predated
that of kinases [1]. Abundant in rabbit muscle and spleen, the phosphatase contemporaneously referred
to as PP1 was shown to remove an inorganic ‘prosthetic group’ from muscle glycogen phosphorylase,
converting it to a less active form. A decade later, inorganic phosphate was hinted at [2] and then
proven [3] as the identity of the removable prosthetic group. It is now clear that hydroxyl-containing
amino acids, i.e., Ser, Thr and Tyr, undergo phosphorylation by protein kinases, while phosphatases
catalyze phosphate removal, thereby controlling steady-state levels of this modification.
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The years following the discovery of PP1 witnessed the identification of many different classes of
phosphatases which can be broadly divided into two groups: one is Protein Tyrosine Phosphatases
(PTPs), which comprises classical PTPs and Dual Specificity Phosphatases (DSP) that catalyze
dephosphorylation of p-Tyr, or p-Tyr, p-Ser and p-Thr residues, respectively [4]. The other family
is Protein Serine/Threonine Phosphatases (PSPs) that dephosphorylate p-Ser and p-Thr residues [5]
(Figure 1). The human genome contains 189 protein phosphatases, encompassing 10 different protein
structural folds and a variety of catalytic mechanisms [6]. This is in contrast to 518 identified human
kinases, whose catalytic domains trace back to a single structural fold [7].
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Figure 1. Protein phosphatases involved in mitosis. Protein phosphatases can be divided into two 
superfamilies: Protein Tyrosine Phosphatases (PTPs) and Protein Ser/Thr Phosphatases (PSPs). 
Although these families contain a vast array of phosphatases, those pertinent to mitosis and discussed 
herein are shown. 
The PTP family is a canopy encompassing diverse phosphatases all of which share the signature 
motif HCx5R (PTP loop). The sulfur atom of the catalytic cysteine initiates a nucleophilic attack on 
the phosphorylated substrate (Figure 2), forming a thiophosphate intermediate that is experimentally 
observable. A conserved aspartate, part of the WPD loop, donates a proton to the dephosphorylated 
protein, leading to its stabilization and eventual dissociation. Next, a water molecule hydrolyzes the 
thiophosphate-enzyme intermediate, again mediated by the aspartate, that accepts a proton from the 
water molecule [4]. 
The PSP family includes a phosphoprotein phosphatase (PPP) subfamily which comprises of 
PP1, PP2A, PP2B/calcineurin, PP4, PP5, PP6 and PP7. These phosphatases have been implicated in 
diverse functions in the cell cycle and beyond. Their catalytic sites adopt similar folds and essentially 
follow the same mechanism of catalysis (Figure 2). Two divalent metal ions—Fe2+ and Zn2+ in native 
enzymes, and two Mn2+ ions in recombinant ones—are coordinated by a number of conserved 
residues involved in metal binding [8,9]. The metal-bound catalytic center holds two water molecules, 
one of which is activated to mount a nucleophilic attack on the phosphate group of the substrate, 
thereby leading to its dephosphorylation in a single step [10]. PP1 and PP2A are the most-studied 
PPPs controlling the cell cycle. PP1 contains surface grooves radiating out from the metal-
coordinating center that bind a plethora of degenerate short docking motifs such as RVxF and SILK, 
to name a few [11]. They mediate interaction of PP1 with hundreds of partner proteins, many of 
which typically employ multiple docking sites to associate with the phosphatase and conscript it for 
various functions. Indeed, it has recently been reported that PP1 starts life as a trimer with inhibitor-
3 and Sds22 acting as inhibitory chaperones, which are then exchanged for other regulatory proteins 
[12–14]. A restricted set of components constitute the trimeric PP2A holoenzyme: a scaffold A 
subunit, a catalytic C subunit and a choice of four families of regulatory B subunits, each with 
multiple isoforms. B55 and B56 families are important in cell division. 
Figure 1. Protein phosphatases involved in mitosis. Protein phosphatases can be divided into
two superfamilies: Protein Tyrosine Phosphatases (PTPs) and Protein Ser/Thr Phosphatases (PSPs).
Although these families contain a vast array of phosphatases, those pertinent to mitosis and discussed
herein are shown.
The PTP family is a canopy encompassing diverse phosphatases all of which share the signature
motif HCx5R (PTP loop). The sulfur atom of the catalytic cysteine initiates a nucleophilic attack on
the phosphorylated substrate (Figure 2), forming a thiophosphate intermediate that is experimentally
observable. A conserved aspartate, part of the WPD loop, donates a proton to the dephosphorylated
protein, leading to its stabilization and eventual dissociation. Next, a water molecule hydrolyzes the
thiophosphate-enzyme intermediate, again mediated by the aspartate, that accepts a proton from the
water molecule [4].
The PSP family includes a phosphoprotein phosphatase (PPP) subfamily which comprises of
PP1, PP2A, PP2B/calcineurin, PP4, PP5, PP6 and PP7. These phosphatases have been implicated in
diverse functions in the cell cycle and beyond. Their catalytic sites adopt similar folds and essentially
follow the same mechanism of catalysis (Figure 2). Two divalent metal ions—Fe2+ and Zn2+ in native
enzymes, and two Mn2+ ions in recombinant ones—are coordinated by a number of conserved residues
involved in metal binding [8,9]. The metal-bound catalytic center holds two water molecules, one of
which is activated to mount a nucleophilic attack on the phosphate group of the substrate, thereby
leading to its dephosphorylation in a single step [10]. PP1 and PP2A are the most-studied PPPs
controlling the cell cycle. PP1 contains surface grooves radiating out from the metal-coordinating
center that bind a plethora of degenerate short docking motifs such as RVxF and SILK, to name
a few [11]. They mediate interaction of PP1 with hundreds of partner proteins, many of which typically
employ multiple docking sites to associate with the phosphatase and conscript it for various functions.
Indeed, it has recently been reported that PP1 starts life as a trimer with inhibitor-3 and Sds22 acting as
inhibitory chaperones, which are then exchanged for other regulatory proteins [12–14]. A restricted set
of components constitute the trimeric PP2A holoenzyme: a scaffold A subunit, a catalytic C subunit
and a choice of four families of regulatory B subunits, each with multiple isoforms. B55 and B56
families are important in cell division.
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the substrate phosphoryl group, leading to substrate dephosphorylation. (C) APC/C E3 ubiquitin 
ligase; ubiquitylation requires the action of three enzymes (E1, E2 and E3). First, the E1 ubiquitin-
activating enzyme uses ATP and catalyzes ubiquitin C-terminal adenylation. Then, an active site 
cysteine on the E1 enzyme attacks the C-terminus of ubiquitin and forms a thioester-linked 
E1~ubiquitin intermediate. The activated ubiquitin is then transferred to an active site cysteine of an 
E2 ubiquitin-conjugating enzyme. Finally, co-activator bound-APC/C (E3 ubiquitin ligase) 
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molecule to a primary amine within the substrate. This process repeats several times, yielding 
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Figure 2. Catalytic mechanisms of protein tyrosine phosphatase (PTP), protein serine/threonine
phosphatase (PSP) and anaphase-promoting complex/cyclosome (APC/C). (A) PTP; the sulphur atom of the
catalytic cysteine, part of the signature PTP loop sequence, initiates a nucleophilic attack on the phosphoryl
group of the substrate and forms a phosphoryl-enzyme intermediate, while the dephosphorylated
substrate receives a proton from the aspartate residue that forms part of the WPD loop. A water molecule
leads to hydrolysis of the phosphoryl group. (B) PSP; enzyme-bound two metal ions (e.g., Fe2+, Zn2+
or Mn2+) coordinate a water molecule that mounts a nucleophilic attack on the substrate phosphoryl
group, leading to substrate dephosphorylation. (C) APC/C E3 ubiquitin ligase; ubiquitylation requires
the action of three enzymes (E1, E2 and E3). First, the E1 ubiquitin-activating enzyme uses ATP and
catalyzes ubiquitin C-terminal adenylation. Then, an active site cysteine on the E1 enzyme attacks the
C-terminus of ubiquitin and forms a thioester-linked E1~ubiquitin intermediate. The activated ubiquitin
is then transferred to an active site cysteine of an E2 ubiquitin-conjugating enzyme. Finally, co-activator
bound-APC/C (E3 ubiquitin ligase) simultaneously binds the ubiquitin-charged E2 and a substrate,
leading to transfer of the ubiquitin molecule to a primary amine within the substrate. This process repeats
several times, yielding polyubiquitylated substrate. Abbreviations: Sub, substrate.
The examples of PP1 nd PP2A highlight a leitmotif in phosphatase function, including ones
controlling cell division: in vivo they tend to function as obligate multimeric enzymes. The catalytic
subunit typically associates with one or more additional subunit. These additional subunits can act as
scaffolds, regulators or inhibitors, thereby fundamentally altering the properties of the phosphatase.
Since early experiments were often performed with the catalytic subunit, phosphatases appeared
to show little discrimination towards substrates. This observation, coupled with the relatively few
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numbers of known phosphatases in comparison to kinases, led to the erroneous yet resilient view that
phosphatases are promiscuous housekeeping enzymes working in the background as their kinase
counterparts orchestrate major cellular events. In theory, this could indeed serve as an organizational
principle in cellular control. For instance, it is well established that oscillating activity of cyclins
in complex with cyclin-dependent kinases (Cdks) propels the cell through various transitions by
orderly phosphorylation of substrate proteins [15,16], with the tacit assumption that many of these
modifications are reversed by background phosphatase activity. Recent research, however, has
challenged this view, and now places these enzymes as sophisticated molecular participants. Substrate
specificities of phosphatases, imbued by both the active site and docking motif receptors within
associated regulatory proteins, are intimately linked to their function [17–27].
Thousands of unique phosphorylation events on almost three-quarters of the proteome have been
reported, regulating division and other cellular functions [19,28,29].
1.2. The Multiprotein Complex APC/C is a Master Regulator of the Cell Cycle
In addition to selective phosphorylation, selective degradation of proteins provides a major avenue
for control of the cell cycle. A few decades following the discovery of phosphatases, it was found that
cells selectively target proteins for degradation by marking them with covalently-attached chains of
ubiquitin, a small, heat-stable protein [30,31]. These chains are recognized and irreversibly destroyed
by the 26S proteasome. Degradation of mitotic cyclins and Cdk1 inactivation during mitotic exit was
then attributed to the ubiquitin-protease system [32], thus marrying together the fields of protein
phosphorylation and ubiquitylation in cell cycle control. In fact, ubiquitin-mediated degradation
was found to be the impetus for cytological anaphase [33], triggered by destruction of securin [34,35],
an inhibitory chaperone for the protease separase. Once released, separase cleaves the kleisin subunit
of cohesin rings that hold sister chromatids together [36].
The attachment of ubiquitin, ‘ubiquitylation’, is a multi-step process with sequential actions of
three enzymes (E1-E2-E3) [37–39]: The C-terminal glycine residue of ubiquitin is first activated by
an E1 ubiquitin-activating enzyme in an ATP-dependent process and then covalently attached to
the active cysteine residue of the E1 by formation of a thioester-ubiquitin conjugate. The activated
ubiquitin is then transferred to the active site cysteine of an E2 ubiquitin-conjugating enzyme. Finally,
an E3 ubiquitin ligase coordinates the transfer of ubiquitin to selected substrates by simultaneously
binding a ubiquitin-charged E2 and a substrate in a productive manner (Figure 2). Attachment of
ubiquitin requires a primary amine within the substrate and typically occurs on lysine residues or
the N-terminal initiator methionine. The C-terminal glycine of ubiquitin forms an isopeptide bond
with an ε-amine of the substrate. Further ubiquitylation can occur on either the N-terminus or any of
the seven lysine residues present within the attached ubiquitin molecule. Polyubiquitylation leads to
formation of different types of ubiquitin chains, leading the protein down different trajectories, one of
which is irreversible degradation [39].
Deubiquitylating enzymes (DUBs) disassemble ubiquitin chains on substrates, providing another
avenue for cellular control and homeostasis. There are about 93 different DUBs in the human genome,
compared to about 600 E3 ubiquitin ligases [40,41], drawing parallels with reversible phosphorylation
in that there is a discrepancy in numbers of enzymes that add a modification compared to ones that
remove it.
The anaphase-promoting complex/cyclosome (APC/C) was found to be the E3 ubiquitin ligase
responsible for degradation of Cyclin B during mitosis [42–44] by which the master regulatory kinase of
mitosis, Cdk1-Cyclin B is switched off, driving cells out of mitosis. The APC/C is a gigantic 1.22 MDa
multi-subunit enzyme belonging to the Cullin-RING family of E3 ligases. In vertebrates, it contains
14 highly conserved subunits—Apc1-8, Apc10-13, Apc15 and Apc16—five of which are present as
dimers. Apc7 is absent from fission and budding yeast complexes. The APC/C itself is not catalytically
active as a ubiquitin ligase. It becomes active only when it associates with a ‘co-activator’ protein
belonging to the Cdc20/Fizzy family, such as Cdc20 or Cdh1. It should be noted that co-activators are not
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stoichiometric components of the APC/C, but their association with the APC/C is essential for its E3 ligase
function [45–47]. Several organisms also contain meiosis-specific co-activators, such as Ama1 in budding
yeast [48], Mfr1/Fzr1, Fzr2 and Fzr3 in fission yeast [49,50], Cort in Drosophila [51], etc. Co-activators
not only act as receptors for the substrate protein to be modified, but also act as catalytic activators and
induce structural rearrangements essential for E2 binding and ubiquitin transfer [52,53]. Some of the
APC/C subunits had already been identified budding yeast genetic screens conducted by Hartwell et al.
for temperature sensitive mutations that cause cell cycle arrest at elevated temperatures [54]. Perhaps
unsurprisingly, this approach also identified the essential budding yeast cell cycle phosphatase Cdc14.
Recent structural studies have illuminated the overall architecture and subunit arrangement of
the APC/C holocomplex. It adopts a hollow triangular shape, with the co-activator binding into this
nook. Together with the core subunit Apc10, a co-activator forms the substrate recognition module
of the enzyme and binds short linear degradation signals, or ‘degrons’ such as the destruction box
(D-box) or the KEN-box present within intrinsically unstructured regions of target proteins [32,55–58].
The catalytic core module is composed of the Cullin-RING subunits Apc2-Apc11, respectively. The rest
of the complex is devoted to co-activator recruitment and scaffolding functions, which are thought to
coordinate optimal placement of the co-activator, the catalytic module and E2 enzymes for productive
catalysis. The tetratricopeptide (TPR) lobe (the substrate recognition sub-complex) consists of the TPR
repeat-containing proteins Apc3 (Cdc27), Apc6 (Cdc16), Apc7 (situated at the apex of the APC/C triangle;
absent in yeast) and Apc8 (Cdc23) proteins that form homodimers, acting as a scaffold for co-activator
binding. On the other hand, the multi-domain subunit Apc1, in conjunction with Apc4 and Apc5, forms
a platform that bridges the catalytic module Apc2-Apc11 and the TPR lobe in a catalytically favorable
conformation. This geometry also enables cell cycle-controlled binding of the APC/C inhibitors: the
Mitotic Checkpoint Complex (MCC), the main effector of a surveillance mechanism called the Spindle
Assembly Checkpoint (SAC) and Emi1 (early mitotic inhibitor), a metazoan APC/C inhibitor which is
a vertebrate homologue of Rca1 (regulator of cyclin A) [59–64].
In humans, it has been reported that 170 proteins are ubiquitylated by the APC/C, likely to be
an underestimate [65]. Due to its importance in regulating entry into and exit from mitosis, cytokinesis
and G1/S transition, APC/C activity is strictly controlled during the cell cycle. During G1, APC/C-Cdh1
activity not only prevents premature entry into S-phase by degrading Cyclins and Skp2, but also
regulates replication origin assembly by degrading regulators of DNA replication (e.g., geminin).
At G1/S, multiple mechanisms, such as direct Cdh1 phosphorylation, Emi1 inhibitor binding and Cdh1
degradation, collaborate to shut off APC/C-Cdh1 activity and trigger S-phase. Emi1 continues to inhibit
APC/C-Cdh1 throughout G2. In mitosis, prior to metaphase, APC/C-Cdc20 activity is restrained by
MCC binding until all of the chromosomes are bi-oriented at the metaphase plate. While SAC prevents
degradation of most substrates, Cyclin A and Nek2A bypass it by directly binding the APC/C [66,67].
Once the SAC is satisfied, APC/C-Cdc20 is unleashed from inhibition to degrade critical substrates
such as Cyclin B and securin, heralding the onset of anaphase [68–71]. The latter stages of mitotic exit
witness Cdh1 activation due to its dephosphorylation by reactivated phosphatases. Cdh1 replaces
Cdc20 as the co-activator for the remainder of mitosis and targets the latter for destruction (Figure 3).
Unidirectional and orderly transitions through cell cycle phases are critical to our initial question of
how cells divide in an error-free manner. Concerning mitotic exit, studies in both yeast and vertebrates
show that APC/C-mediated proteolysis and dephosphorylation work in concert to ensure irreversible
transition through this phase and establish a biochemically G1 state [72,73].
The APC/C and phosphatases exhibit considerable crosstalk during mitosis; they influence
each other directly and indirectly. Broadly, APC/C activation during mitosis requires phosphorylation
and is opposed by phosphatase action. Association of co-activators with the APC/C, however, requires
them to be dephosphorylated by phosphatases. Phosphatases are also essential to silence the SAC and
further promote APC/C activation. Active APC/C catalyzes mitotic cyclin degradation (inactivation
of Cdk1) which then leads to phosphatase reactivation. These observations outline the interlinked
nature of an extensive network of phosphorylation and ubiquitylation throughout M-phase and will
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be explored in greater detail in the following sections. Readers interested in detailed kinase and
phosphatase crosstalk governing kinetochore-microtubule attachments and the SAC that are beyond
the scope of this review are pointed to recent excellent comprehensive reviews [74–78].
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2. G2/M Transition
2.1. Cdc25 Promotes Cdk1-Cyclin B Activation and Mitotic Entry
As mentioned previously, a quantitative increase in Cdk activity from G1 to M-phase triggers
sequential passage through the cell cycle. Transition from G2 to M-phase requires an explosive,
switch-like activation of Cdk1-Cyclin B. During G2, although the synthesis of Cyclin B increases due to
transcriptional activation, concomitant increase in associated kinase activity requires removal of two
inhibitory phosphates on the Cdk1 subunit: p-Thr14 and p-Tyr15. Phosphorylation of these residues
prevents catalysis by causing ATP misalignment [79], and is performed by the inhibitory kinases Wee1
and Myt1. The dual-specificity PTP Cdc25 dephosphorylates these residues. Cdk1-Cyclin B catalyzes
its own activation by phosphorylating both Wee1 and Cdc25 to opposite effects: inactivating the former
but activating the latter, thus generating double negative and positive feedback loops. In addition,
PP2A has long been known as a negative regulator of Cdk1 activation [80–83]. These activities underlie
a bistable switch leading to swift Cdk1 activation and irreversible mitotic commitment [84,85], although
studies in Xenopus indicate that preceding Cdk1-Cyclin A-mediated phosphorylation sets in motion
mitotic commitment [86].
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In humans, three Cdc25 paralogues exist; Cdc25A, Cdc25B and Cdc25C and perform distinct but
overlapping functions in Cdk activation. Active Cdk1-Cyclin B first emerges at centrosomes, catalyzed
by Cdc25B. In fact, centrosome splitting proceeds a few minutes after emergence of active kinase in
unperturbed cells [87]. In a spatial positive feedback loop, partially activated cytoplasmic pool of
Cdk1-Cyclin B then translocates into the nucleus driven by phosphorylation of the Cyclin N-terminus,
where it eventually promotes nuclear envelope breakdown [88–90]. Nuclear pools of Cdc25A and
Cdc25C promote further activation of the kinase.
The activity and subcellular localization of these phosphatases are themselves modified through
phosphoregulation and proteolysis. For instance, phosphorylation of Cdc25C by Cdk1 and Polo-like
kinase (Plk) increases its activity. Additionally, Cdc25C phosphorylation by a number of kinases at
a 14-3-3 consensus sequence leads to its cytoplasmic retention and catalytic inactivation by these
adaptor proteins [91,92]. An initial Cdk1-mediated phosphorylation allows PP1 binding to Cdc25C
via its N-terminal RVxF motif. In a phosphatase relay, PP1 dephosphorylates the 14-3-3 docking site
within the protein, thereby relieving Cdc25C from inhibition to dephosphorylate Cdk1 [93,94]. At the
end of mitosis, Cdc25A is degraded by APC/C-Cdh1, thus further promoting Cdk1 inactivation [95].
2.2. Phosphatases are Downregulated at Mitotic Entry
Thousands of proteins are phosphorylated during mitosis by Cdk1, Plk, Aurora A and Aurora B,
to name a few. They drive the dramatic cytological changes one associates with this phase: reorganization
of cortical cytoskeleton to induce cell rounding and dissolution of the nuclear envelope in vertebrates,
compaction of chromosomes to aid segregation and formation of a spindle structure to capture and biorient
chromosomes at the metaphase plate. A coherent forward step towards this phase would dictate that opposing
phosphatase activity be dampened, swinging the balance towards phosphorylation. Downregulation of
many phosphatases occurs at this juncture through direct Cdk1-dependent phosphorylation or binding of
various small, heat-stable inhibitors (see below).
Increasing Cdk1 kinase levels phosphorylate the highly conserved AGC kinase Greatwall. The two
phosphorylated residues lie within the activation loop of the kinase domain and produce a partially
activated enzyme. Intramolecular autophosphorylation of its C-terminal tail leads fully active Greatwall
by stabilization of its active conformation [96,97].
Active Greatwall phosphorylates two small, heat-stable, intrinsically unstructured proteins: ENSA
(α-endosulfine) and Arpp19 (cAMP-regulated phosphoprotein 19) [98,99]. Phosphorylation occurs
at a Ser residue within a highly conserved motif present in both proteins and transforms them into
potent inhibitors of PP2A-B55 holocomplexes. Specificity for the B55-bound form of PP2A arises as the
proteins bind at the interface of B55 and the catalytic subunit, occluding the active site [100].
In keeping with a paradigm often governing enzyme-inhibitor interactions, PP2A-B55 itself is able to
dephosphorylate p-ENSA/p-Arpp19, albeit very slowly, with a kcat two-three orders of magnitude lower
than that of a generic PP2A-B55 substrate. PP2A-B55—p-ENSA Km is about four orders of magnitude
lower than that for a phosphosubstrate, indicating very tight binding of the inhibitor. Strong inhibitor
binding coupled with low rate of catalysis has been termed ‘inhibition by unfair competition’ [101].
This implies that as long as p-ENSA is replenished by active Greatwall, the mitotic state will be preserved
through phosphatase inhibition. In summary, Cdk1 phosphorylation of Greatwall leads to its activation
and phosphorylation of ENSA/Arpp19—inhibitors of PP2A-B55.
PP2A-B56 is present at kinetochores, where it phosphoregulates kinetochore-microtubule
interactions, and is opposed by Aurora B. Phosphorylation of another small, heat-stable protein
Bod1 recruited by Ndc80 causes it to inhibit PP2A-B56 complexes. This inhibition is proposed to maintain
the correct balance of PP2A-B56 and Aurora B activities [102,103], although detailed mechanisms
remain elusive.
Direct phosphorylation of PP2A subunits has also been reported to regulate enzyme activity by
affecting assembly. Human PP2A catalytic subunit phosphorylation at its C-terminal tail at Thr307
prevented binding of B55 [104]. A recent study reported that phosphorylation of Thr174 of the budding
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yeast B55 by mitotic Cdk led to inhibition of its phosphatase activity [105]. Phosphorylation of the
equivalent site Ser167 on human B55α, possibly by Cdk1-Cyclin B, inhibits holoenzyme assembly [106].
Cdk1 also directly phosphorylates PP1 near its C-terminus at Thr320 to inhibit its activity down
to 30–40% of its peak levels [107–109]. Protein Kinase A phosphorylates Inhibitor-1 (l-1), a small
heat-stable protein inhibitor, which then specifically inhibits PP1 [110]. In fact, inhibition by I-1 was
often used to discriminate between PP1 and PP2A enzymes isolated from tissues in early studies [111].
Importantly, PP1 phosphorylation and I-1 inhibition are thought to act in concert to suppress its
phosphatase activity. In an analogous paradigm to PP2A-B55 inhibition, PP1 itself removes these
inhibitory phosphates, albeit slowly [110].
As previously mentioned, PP1 binding proteins often employ one or more short docking motifs to
interact with the enzyme. Of its 200 known interactors, at least 90% employ the RVxF motif [11]. When
the ‘x’ within the motif is a Ser or a Thr, it conforms to a basophilic motif preferred by the mitotic kinase
Aurora B [112]. Indeed, Aurora B-mediated phosphorylation of these motifs prevents PP1 holoenzyme
assembly during mitosis [113], representing another mode of PP1 inhibition.
PP6 is a phosphatase belonging to the PPP superfamily that also forms a heterotrimeric enzyme.
It dephosphorylates the regulatory T-loop of Aurora A thus inhibiting its activity at centrosomes [114].
During mitosis, Cdk1 phosphorylation of the PP6 regulatory subunit creates a docking site for
Plk1, which then phosphorylates the phosphatase complex at multiple sites and inhibits its activity
through unknown mechanisms. Thus, PP6-mediated signaling is temporally inhibited to ensure
a preponderance of Aurora A activity [115].
Another ubiquitous phosphatase of the PPP family, PP4, forms heterodimeric or heterotrimeric
complexes in vivo [116,117], presumably leading to different substrate specificities or subcellular
localization. For instance,DrosophilaPP4 is targeted to centromeres via interaction of its regulatory subunit
R3 with the centromere protein CENP-C, where it regulates centromeric integrity during mitosis [118].
It has also been implicated in mitotic centrosome function in Drosophila [119], C. elegans [120] and
humans [121]. At the G2/M transition, rising Cdk1-Cyclin B activity leads to phosphorylation of a PP4
complex at centrosomes to inhibit its activity. As PP4 opposes γ-tubulin phosphorylation, its inhibition
enables formation of the mitotic spindle [121].
During metaphase/anaphase, APC/C-mediated degradation of Cyclin B and various mitotic
kinases sets in motion cascade of events that lead to reactivation of phosphatases (Figure 3). Thus,
the APC/C is essential for phosphatase function during mitotic exit.
It is important to note that while there is a general swing towards kinase activation, some phosphatase
activity is preserved throughout mitosis. Indeed, it is essential for mitotic progression. As is discussed in
the next few sections, PP1 and PP2A-B56 activity at kinetochores plays an important role in stabilizing
amphitelic kinetochore-microtubule linkages and silencing the SAC. These phosphatases have also been
implicated in dephosphorylating the APC/C co-activator Cdc20 and initiating anaphase [122–124]. It is
possible that association with certain structures within the cells precludes inhibitor binding, just as
microtubule binding protects spindle assembly factors from APC/C-mediated turnover [125]. Another
possibility is that these phosphatases are locally reactivated. How these complexes evade inhibition or
achieve local reactivation is an important question for the future.
3. Building a Metaphase Cell
3.1. PP1 and PP2A Phosphatases Regulate Kinetochore Capture by Microtubules
Successful execution of chromosome segregation requires capture of kinetochore by microtubules
emanating from spindle poles or centrosomes at the opposite ends of the cells. This ensures that
each daughter cell gets one copy of the genome. Until all sister chromatids have correctly attached,
kinetochores activate the SAC and hold cells in metaphase by inhibiting the APC/C. Thus, phosphatase
mediated error correction and SAC inactivation are intimately linked to APC/C activation. In turn,
APC/C degrades many proteins involved in these processes. Kinetochore capture is a stochastic process;
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many rounds of incorrect attachments precede mature, end-on attachments [126–128]. It is imperative
that only bioriented chromosomes attached to the spindle be selectively stabilized.
How does the cell recognize correct attachments? On a molecular level, this occurs through
warring activities of kinases and phosphatases at the centromere and kinetochore. Central to error
correction is the kinase Aurora B, which is recruited to inner centromeres in two different ways.
First, the mitotic Haspin kinase phosphorylates histone H3 at Thr3, which directly binds the Aurora
B-containing Chromosome Passenger Complex (CPC) subunit Survivin [129]. Second, Bub1, a mitotic
kinase, phosphorylates H2A at Thr120 at centromeres, which then leads to the recruitment of
shugoshin-CPC [130]. Centromeric shugoshin contributes to another pool of Aurora B [131]. Upon
autophosphorylation of its T-loop, possibly in trans, active Aurora B phosphorylates several kinetochore
proteins and severs incorrect interactions with microtubules, thus giving them a chance to pursue
correct ones. Among other proteins, the outer kinetochore subunit Ndc80 is the focal point of Aurora B
kinase activity. Phosphorylation of its N-terminus reduces its affinity for microtubules and disfavors the
connection [132]. Aurora B also phosphorylates the kinetochore localized Ska complex in metazoans,
which is capable of efficiently binding curved ends of depolymerizing microtubule protofilaments.
Thus, by helping kinetochores hold on to different microtubule architectures and states, the Ska complex
enables ‘end tracking’. Phosphorylation reduces Ska-Ndc80 binding, dampening its affinity for the
spindle microtubules [133,134]. Targets of Aurora B are also modulated by other kinases such as Cdk1,
Plk1 and Mps1 in this endeavor [74].
A collaboration between PP1 and PP2A-B56 phosphatases, recruited through many mechanisms,
leads to direct dephosphorylation of Aurora B substrates to strengthen kinetochore-microtubule
interactions. PP2A-B56 directly binds the outer kinetochore, and serves to stabilize initial microtubule-
kinetochore contacts, enabling them to form mature, end-on attachments [135]. B56-bound complex is
drafted to an unattached outer kinetochore by directly binding the spindle checkpoint protein BubR1
via a LxxIxE motif. To give an example of the complex cross-talk at these regulatory foci, Cdk1 and
Plk1 positively regulate PP2A-B56 binding in this context by phosphorylating residues within and
downstream of the motif and enhancing B56 binding [24–27]. This population of the phosphatase
opposes Aurora B phosphorylation of the PP1-binding RVxF motif in the outer kinetochore protein
Knl1 and allows its recruitment [136]. PP1 can also be delivered to the site of action by binding to plus
end-directed motors such as CENP-E. Analogous to its Knl1 binding, PP1 interaction with CENP-E
is blocked by Aurora A- (at spindle poles) and B-mediated phosphorylation of a threonine within its
RVxF motif. Once dephosphorylated, PP1-CENP-E stabilizes mature attachments [137]. Finally, the Ska
complex can also directly engage PP1 [138].
As previously mentioned, Cyclin A is degraded during prometaphase by APC/C action, even
though the spindle checkpoint is active. Timely degradation of Cyclin A at this juncture is essential
for formation of stable kinetochore-microtubule (KT-MT) attachments [139]. The question remains of
how Cyclin A evades the SAC. As kinase activity rises in mitosis, APC/C subunits are phosphorylated.
The Cdk accessory subunit Cks1/2, in the form of Cyclin A-Cdk-Cks, independently recruits Cyclin A to
the APC/C by binding phosphorylated residues within the latter and leads to its ubiquitylation [67,140].
Thus, APC/C action in prometaphase enables correct KT-MT attachments by limiting Cyclin A-associated
kinase activity.
Once correctly attached, the two sister chromatids are pulled to opposite poles of the cell, thereby
generating tension that is thought to place the kinetochore proteins outside the zone of influence
of inner centromere localized Aurora B, more than 100 nm away [141]. Here, phosphatase activity
predominates and preferentially stabilizes these attachments [142], through direct dephosphorylation
of seminal targets such as Knl1 and Ndc80.
During mitotic exit, BubR1 (Mad3 in yeast, worms and plants) and Bub1 are targeted for
degradation by the APC/C [143,144], shutting down PP2A-B56 recruitment and SAC signaling
(discussed below). PP1, now in complex with Repo-Man, nips Aurora B signaling at the bud by
dephosphorylating H3 p-Thr3 [145,146]. Aurora B is also physically evicted from the inner centromere
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to the central spindle. Dephosphorylation of budding yeast CPC subunit Sli15 (INCENP) by Cdc14
precipitates this event [147]. In humans, this role is performed by PP2A-B55 [21]. Finally, Aurora
kinases are degraded by APC/C action in late mitosis, thus ensuring that their phosphosignaling is
temporally constrained within the cell.
3.2. The Spindle Assembly Checkpoint Inhibits APC/C Activity in Metaphase and is Regulated by Phosphatases
Until all kinetochores are correctly captured and bioriented at the metaphases plate, the APC/C
activity is held in check by a highly potent, diffusible complex that acts as a stoichiometric inhibitor—the
Mitotic Checkpoint Complex (MCC). Even one unattached kinetochore can sequentially recruit an array
of proteins to form the MCC, holding the entire cell in metaphase and safeguarding genome segregation.
The MCC is a complex composed of Mad2, BubR1, Cdc20 and Bub3. At unattached kinetochores,
the Ndc80 complex, unfettered by microtubule binding, instead recruits the kinase Mps1 and drives
a phospho-dependent signaling cascade. By virtue of being present at the outer kinetochore, Mps1
phosphorylates various proteins, including the MELT motifs of Knl1. This is the most upstream event in
the MCC formation. As seen during error correction, Knl1 again acts as a scaffold and recruits Bub1-Bub3
complexes via its phosphorylated MELT motifs, which then recruit BubR1-Bub3 complexes. At this
juncture, Mps1 directly phosphorylates Bub1 and leads to Mad1-Mad2 heterodimer binding [78]. Next,
Mad1 phosphorylation by Mps1 stimulates its catalytic activity, and leads to conversion of open-Mad2
(o-Mad2), to the MCC-assembly competent closed-Mad2 (c-Mad2) by structural remodeling of the
protein [148]. This process is critical to rapid MCC assembly and therefore instantaneous checkpoint
response within the cell. Termed a ‘template-assisted mechanism’, Mad1-c-Mad2 heterodimers
catalyze conversion of cytosolic o-Mad2 proteins to their closed conformers at unattached kinetochores.
Importantly, spontaneous Mad2 conversion is disfavored outside the context of kinetochores as the
protein faces a large energy barrier [149,150]. C-Mad2 is the structurally relevant form of the MCC.
By capturing Cdc20 via its N-terminal KILR motif, it leads to MCC formation. MCC binds APC/C
complexes already containing a bound Cdc20 co-activator and inhibits their activity [151]. Cdk1 and
Plk1 kinases impinge at various stages throughout this process, for instance by directly phosphorylating
Mps1 to enhance its kinase activity [74,152,153].
It was initially thought that the MCC functions by sequestering Cdc20 away from the APC/C.
Recently, however, it has become clear that the MCC employs a multitude of mechanisms to target
numerous aspects of APC/C function to obstruct its activity. Cryo-electron microscopy structures have
revealed molecular details of APC/C-MCC interactions [61,64]. The hollow of the APC/C is occupied
by the MCC complex and its own molecule of Cdc20. MCC binding causes the APC/C-bound Cdc20 to
move away from Apc10, thus disrupting D-box binding site within the holocomplex. BubR1, by virtue
of its various inhibitory degron motifs (D-box, KEN and the ABBA motifs), mounts a multi-pronged
attack on the two Cdc20 molecules within the complex [56,61,64]. It caps all available degron-binding
sites within Cdc20, hobbling any potential for substrate recruitment. In some conformations, BubR1
also precludes binding of the initiating E2 UbcH10 by occupying its binding site within the catalytic
module at the base of the enzyme. In a different state however, possibly regulated by the Apc15 subunit
of the enzyme, the MCC rotates away and vacates the initiator E2 binding site. How the APC/C switches
between the two conformations is unclear. Subsequent UbcH10 binding to the second conformer
allows ubiquitylation and degradation of the Cdc20 molecule within the MCC, thereby leading to
MCC turnover [61,64]. Thus, APC/C-bound MCC is a dynamic, self-limiting inhibitor with an inbuilt
‘diffuse’ function. Cdc20 turnover is important for cells to recover from a SAC arrest and avoid cohesion
fatigue. Cdc20 levels are replenished by synthesis during mitosis [154]; as long as kinetochores remain
unattached, the MCC will continue to inhibit the E3 ligase. This process is continuously antagonized
by the DUB Usp44 to maintain a fine balance of Cdc20 levels [155,156]. Another protein antagonizes
MCC assembly: p31comet adopts a Mad2-like fold, and extracts c-Mad2 from its complex with Mad1
and from within the MCC by directly dimerizing with it [157,158]. p31comet also acts as an adaptor
protein and delivers c-Mad2 to the AAA+ ATPase TRIP13, which then catalyzes its conversion to
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inactive o-Mad2 by ATP hydrolysis and inactivates the MCC [159]. Phosphorylation has been reported
to regulate p31comet activity in Xenopus and humans [160–162]. However, the details of the molecular
mechanism are unclear, as is the nature of phosphatases that regulate this process.
Finally, in addition to MCC dissociation, further SAC signaling must also be extinguished at the
source to ensure timely anaphase entry. Indeed, kinetochores proteins are in a state of flux due to
presence of both kinases (Aurora B and Mps1) and recruited phosphatases (PP2A-B56-BubR1 and
PP1-Knl1), which enables quick responsiveness of the system to changes in the input. Once the Ndc80
complex is bound to kinetochores, Mps1 can no longer bind and initiate its signaling cascade and MCC
formation [163]. Direct dephosphorylation of Mps1 substrates is also required to prevent any potential
for further MCC formation and is achieved by PP1 and PP2A phosphatases. PP1, recruited to outer
kinetochores in a number of ways, is thought to take the lead in Mps1 substrate dephosphorylation [74].
PP1-Knl1 directly dephosphorylates Knl1-MELT motifs to halt any further binding of Bub1. PP2A-B56
bound to BubR1 is also thought to dephosphorylate Bub1, in addition to its role in recruiting PP1 by
dephosphorylating its docking motifs within Knl1 [164–166]. As the same phosphatases regulate both
error correction and SAC silencing, their interplay, in particular together with Aurora B and Mps1
kinases is complex. However, it is vital to understand how the antagonistic activities are integrated [74].
These molecular interactions underlie the highly responsive nature of MCC-mediated inhibition
and explain how cells commence Cyclin B degradation as soon as the last chromosome is aligned [167].
3.3. Constructing and Segregating Mitotic Chromosomes
One of the hallmarks of the mitotic phase is the appearance of discrete, rod-shaped ‘condensed’
chromosomes, a prerequisite for accurate chromosome segregation to daughter cells. This is mediated by
actions of two different SMC (structural maintenance of chromosome) protein complexes, condensin and
cohesin [168,169]. They govern sister chromatid resolution, chromosome compaction and segregation,
and are subject to regulation by kinases, phosphatases and the APC/C.
Condensin I and condensin II are ring-shaped multisubunit complexes that perform distinct
functions in chromosome organisation and segregation in mitosis. In vitro reconstitution of mitotic
chromatids has revealed that Cdk1 phosphorylation of condensin I is the sole mitosis-specific
modification required for chromatid reconstitution [170]. Nonetheless, actions of Cdk1, Plk1 and
Aurora B are also implicated in chromatin targeting of distinct condensin complexes and stimulating
their activity [171–176]. In budding yeast, Cdc14 dephosphorylates the Smc4 subunit of condensin
during mitotic exit [177]. In higher organisms, PP2A has been implicated in regulating condensin [178].
Additionally, PP6 has also been shown to positively regulate condensin I complexes by opposing
inhibitory phosphorylation by casein kinase 2 [115,179].
Cohesin is a ring-shaped proteinaceous complex that holds together duplicated sister chromatids
by physically entrapping them. Cell cycle-dependent acetylation of one of the cohesin subunits serves to
‘lock’ the ring in both yeast and vertebrates. Sororin, a vertebrate-specific protein is specifically recruited
to acetylated cohesin. It protects cohesin from the ‘anti-establishment’ activity of a negative regulator,
Wapl. Following entry into mitosis, vertebrate cells witness a removal of majority of cohesin complexes
due to extensive phosphorylation of both Sororin and Wapl catalyzed by Cdk1, Plk1 and Aurora B.
This occurs concomitant to condensin activity. Sororin phosphorylation destabilizes its interaction
with cohesin, allowing Wapl activity to predominate [180,181]. Centromeric cohesin is preserved until
anaphase through recruitment of PP2A-B56, which antagonizes these phosphorylation events and
holds sister chromatids together until anaphases commences [182,183]. A mitosis-specific signaling
cascade ensures the presence of PP2A-B56 complexes where their action is needed. As previously
mentioned, Bub1 recruits Sgo1 by phosphorylating histone H2A at Thr120 [130]. Sgo1 directly binds
PP2A-B56 through contacts with both the catalytic and regulatory subunits [184]. Bub1 degradation
during anaphase turns off this pathway [185]; however, the identity of the phosphatase that resets H2A
p-Thr120 is unknown.
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Anaphase onset liberates separase by APC/C-Cdc20-mediated degradation of its inhibitor, securin.
Centromeric cohesin is cleaved by this protease and sister chromatids commence their movement to
opposite poles of the cell. A collaboration with PP2A-B56 phosphatase ensures that this step ensues in
a switch-like fashion and precedes later events such as cytokinesis, which can damage any lagging
chromosomes. CaMKII phosphorylates securin and makes it more amenable to APC/C-mediated
degradation by increasing its degron-APC/C affinity. Separase-bound securin, however, is kept in
a hypophosphorylated state by recruitment of PP2A-B56. Thus, free securin is targeted by the APC/C
before separase-bound securin, ensuring that liberated separase is not re-inhibited by remaining securin
molecules. Once activated, separase self-cleavage precludes PP2A binding and therefore re-inhibition
by securin [186–188].
In budding yeast, securin degradation and decisive anaphase onset is also under phosphatase
control, albeit with different underlying molecular details. Phosphorylation of yeast securin by
Cdk1 impedes its degradation. As small levels of securin are degraded by the APC/C, Cdc14 is
liberated, which dephosphorylates securin, promoting its degradation. Thus, a positive feedback loop
is generated that leads to switch-like anaphase onset [189].
Major interactions between cell cycle phosphatases and the APC/C are outlined in Figure 4.
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Figure 4. The P / and cell cycle phosphatases display complex interactions, influencing not only each
other but also numerous events in mitosis and transition into anaphase. Black arrows indicate stimulation;
red T-bars indicate inhibition. See text for details. Abbreviations: CycB, Cyclin B; de-p, dephosphorylation;
deg, degradation; KT-MT, kinetochore-microtubule; p, phosphorylation; Ub, ubiquitylation.
4. Intricate Interplay between Phosphatases and the APC/C Regulates Metaphase-Anaphase
Transition and Mitotic Exit
Once all chromosomes are aligned and the SAC is switched off, APC/C-Cdc20 becomes active.
In addition to securin destruction, Cyclin B also gets degraded which reduces the overall kinase
activity and initiates phosphatase reactivation. Extensive phosphoregulation of both the APC/C and
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co-activators governs its activity throughout mitosis. Phosphorylation precipitates opposite outcomes
in this regard: phosphorylation of the APC/C activates it while co-activator phosphorylation prevents
its association with the E3 ligase. Figure 5 summarizes control of APC/C function by phosphatases.Cells 2019, 8, x 13 of 34 
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Figure 5. Phosphatases regulate multiple aspects of APC/C function. (A) In mitosis, PP2A-B56 and PP1
dephosphorylate phosphothreonine-rich Cdc20 N-terminus to promote its interaction with the APC/C.
During mitotic exit and in G1, PP2A-B55 (and other mitotic exit phosphatases) dephosphorylate serine-rich
Cdh1 N-terminus. In conjunction with other unknown mechanisms, this promotes co-activator exchange
and Cdc20 degradation. (B) Apc1Loop300 occludes the C box binding site within Apc8 and prevents
Cdc20 loading. Recruitment of mitotic kinases by Apc3Loop leads to Apc1Loop300 phosphorylation (likely
opposed by as-yet-unknown phosphatases) and Cdc20 loading. (C) Phosphoregulation of degrons
influences substrate degradation by the APC/C. Securin phosphorylation at position 6 within the D-box
stimulates its degradation. PP2A-B56 opposes this process. Budding yeast Dbf4 phosphorylation at
position 2, removed by Cdc14, is refractory to its degradation. See text for details. Abbreviations: CycB,
Cyclin B; Sub, substrate.
4.1. Phosphorylation of APC/C Enables Cdc20 Binding
Co-activators bind to APC/C at multiple sites, employing evolutionarily conserved regions within
their largely in rinsically unstructured N- and C-terminal tails. These tails flank the highly structured
WD40 propeller domain, which only mediates substrate recruitment rather than APC/C association.
Of chief importance ar two short linear binding ot fs within co-activators (the C box and IR tail)
that ooperatively enable Cdc20 nd Cdh1 association with the APC/C by binding to the TPR lobe
(the substra e re gnition sub-complex). The C box, named so due to its evolutionary conservation
within Cdc20 family of proteins [190], typically li s close to the N-ter inus f co-activators and docks
into one of the cop es of the TPR subunit Apc8 [60,124]. The Ile-Arg or IR tail at the v y C-terminus
Cells 2019, 8, 814 14 of 33
of co-activators binds an equivalent site within Apc3 [191]. The equivalence of the C box and IR tail
receptor sites is demonstrated by the fact that the IR tail of the Cdc20 molecule within the MCC binds
the Apc8 subunit instead [61,64]. Interestingly, the core subunit Apc10, the inhibitor Emi1, the E2
enzyme Ube2S and the prometaphase substrate Nek2A also employ the IR tail or variations thereof to
associate with the APC/C [60–64,66].
Although both co-activators possess these binding sites, it had long been known that Cdc20 can only
bind APC/C hyperphosphorylated in early mitosis by Cdk1 and Plk kinases [192–196]. Cdh1-mediated
activation, however, is not conditional on APC/C phosphorylation status [193] and occurs towards
the end of mitosis and G1. At this stage, APC/C phosphorylation is low due to Cdk1 inactivation
by kinase degradation and Wee1 activity, and concomitant action of reactivated phosphatases. This
dichotomy was resolved by cryo-EM, biochemical and functional analyses and unveiled a sequential
phosphorylation relay that activates the APC/C by allowing Cdc20 binding [197–199]. Apc1 and Apc3
subunits were found to be hyperphosphorylated within two intrinsically unstructured loop domains:
a large ~280 residue segment within Apc3, and a shorter ~100 residue stretch within Apc1 at position
300 from the N-terminus (Apc1Loop300), both of which are conserved in vertebrates. Mutation of
Apc3 or Apc1 sites of phosphorylation to alanine considerably reduced APC/C-Cdc20 activity, with
simultaneous mutation of both rendering it almost inactive and unable to bind Cdc20 [197]. It was
found that Apc3 phosphomutant failed to recruit the phosphoadaptor subunit p9/Suc1/Cks [197],
which had been known to interact as a part of cyclin B-Cdk1-Cks complex [200,201]. This led to
downstream effects in the form of reduced Apc1 phosphorylation. Thus, initial phosphorylation of
Apc3 by Cdk1 and polo-like kinases creates a phosphodocking site for p9/Suc1/Cks, probably through
p-Thr residues that conform to its preferred docking motif [202,203], which then leads to intramolecular
phosphorylation of Apc1Loop300. These results pointed to an inhibitory function for Apc1Loop300 that
is relieved upon its phosphorylation. Cryo-EM studies revealed that this loop contained a stretch
similar to the co-activator C box and physically occluded the C box binding site within Apc8 in the
non-phosphorylated form of APC/C [198,199]. Phosphorylation of sites within Apc1Loop300 peels it
away from this region by disrupting its interactions and allows Cdc20 binding. Consistent with this
model, deletion of Apc1Loop300 in the context of the holocomplex permitted Cdc20-dependent activity
even in the absence of phosphorylation [198,199]. Recombinant Apc1Loop300 could co-precipitate
holo-APC/C while its phosphomimetic counterpart could not, further bolstering this conclusion [197].
Thus, intrinsically unstructured regions of the APC/C act as regulatory hubs to control its activity. It is
conceivable that phosphatase recruitment to the APC/C is at least partly mediated through similar
docking interactions. Recruited phosphatases could also be involved in dephosphorylating co-activator,
thereby activating the complex (see below).
Phosphorylation only affects access of Cdc20 to the APC/C, with Cdh1 evidently outcompeting
the autoinhibition of Apc1Loop300 to bind the enzyme. Higher affinity of Cdh1 compared to Cdc20
for the E3 ligase, evidenced by increased interaction sites within its N-terminus with multiple APC/C
subunits, and reduced flexibility of the IR tail within Apc3 in cryo-EM structures has been suggested
as an explanation for their differential behavior [198,204].
The budding and fission yeast APC/C adopts a very similar architecture to its vertebrate counterpart
(barring the absence of Apc7) [205–207]. There is compelling evidence for phosphorylation-mediated
activation of the yeast enzyme [192,208]. It is likely that this is general mechanism of cell cycle-mediated
control of this E3 ligase and is evolutionarily conserved. A loop domain within Apc1, or within
a different subunit in both yeasts might be implicated in this regulation.
A majority of APC/C subunits undergo phosphorylation [198,199]. Whether these impinge on the
Apc3-Apc1 pathway or regulate other functions of the APC/C (such as MCC, Emi1 or phosphatase
binding) remains to be elucidated.
At some point following entry into anaphase, APC/C dephosphorylation occurs and increased
electrophoretic mobility of Apc3 is readily observed by SDS-PAGE [124]. Precisely when this occurs in
the context of other cell cycle events is unknown, but it likely follows reactivation of PP1 and PP2A-B55
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phosphatases. Dephosphorylated Apc3 would no longer support further Apc1 phosphorylation. Thus,
it is possible that Apc1Loop300 is protected from, or impervious to dephosphorylation in early anaphase
to preserve Cdc20 function. APC/C is not homogenously distributed throughout the cell. For instance,
it is localized to mitotic chromosomes by the Ska complex in a dephosphorylated yet active form [209].
How this localization is mediated and how its hypophosphorylated state reconciles with our current
view of APC/C function are unknown.
4.2. Co-Activator Dephosphorylation is Essential for APC/C Interaction
As mentioned previously, Cdc20 is an early activator of the APC/C, while Cdh1 takes the reins in
late mitosis upon its dephosphorylation. The overall structure and organization of the co-activators is
remarkably similar; nonetheless, important differences persist and define their characteristic behaviors.
First, Cdc20 can only bind phosphorylated APC/C due to reasons outlined in the previous section.
Secondly, both co-activators employ the use of D- and KEN boxes within their substrates; however, only
vertebrate Cdc20 appears to bind the ABBA motif which contributes to its inhibition by BubR1 [56].
Budding yeast Cdh1 and Cdc20 also appear to have slight variations within their preferred ABBA
motif signatures [58,210]. Finally, in the absence of Cdh1, Cdc20 is able to compensate for most of its
functions, possibly due to its stabilization as it is degraded by action of APC/C-Cdh1. Efficient Aurora
A and B degradation, however, appears to be dependent on Cdh1 [211].
In contrast to APC/C, Cdk1 phosphorylation of both Cdc20 and Cdh1 is inhibitory and prevents
their association with the E3 ligase [124,212–214]. In early anaphase, Cdc20 phosphorylation at several
sites within its N-terminal tail reduces its affinity for the APC/C in an additive manner. Preserving the
function of any one site while mutating the rest does not elicit the same inhibitory effect. Nonetheless,
a p-Thr site flanking the Cdc20 C box appeared to be particularly inhibitory and phosphorylation of
three threonine residues (Thr64/Thr68/Thr79 in Xenopus Cdc20) largely inhibits the activation role
of Cdc20 [124]. Coupled with the observation that the C box flanking phosphosites are disordered
within cryo-EM structures [198,199], it appears that negative charges and/or bulky phosphate groups
destabilize C box receptor interactions [197].
As Cyclin B is degraded, the previously inhibited phosphatases PP1 and PP2A-B55 get reactivated
(discussed later). Cdh1 is dephosphorylated, probably primarily by active PP2A-B55 in vertebrates [21],
and replaces Cdc20 as the co-activator. Prior to late anaphase, phosphorylation of Cdh1 at its N-terminus
precludes its APC/C binding [193,212]. Analogous to Cdc20 regulation, Cdh1 phosphorylation
destabilizes the interaction of its C box and other affinity elements with the APC/C [60].
A recent study addressed how PP2A-B55 creates distinct temporal windows for co-activator
dephosphorylation and activation: while Cdc20 is dephosphorylated in early anaphase, Cdh1 is only
targeted later. Phosphothreonine residues within Cdc20 are preferred PP2A-B55 substrates compared
to phosphoserines, a property likely shared by all members of the PPP family owing to the similarities
of their catalytic cores. This allows faster activation of Cdc20 by preferential dephosphorylation of its
residues that are mostly Thr. In contrast, p-Ser residues predominate Cdh1 N-terminus and are disfavored
PP2A substrates. Their dephosphorylation occurs later in anaphase when other factors such as reduced
substrate competition possibly make its dephosphorylation more amenable. Importance of late Cdh1
dephosphorylation is underscored by the aberrant mitotic phenotypes associated with a phosphothreonine
variant of the co-activator that is dephosphorylated earlier [21]. How PP2A enzymes select a p-Thr is
unknown. It has been suggested that a small hydrophobic cleft close to the metal ion binding sites at the
catalytic core could make additional contacts with the extra methyl group that differentiates a threonine
from a serine [215]. This could translate into p-Thr residues exhibiting a lower Km, a higher kcat or both,
instigating faster turnover. In summary, both Cdc20 and Cdh1 are dephosphorylated at different points in
the cell cycle to drive APC/C activation.
Cdc20 dephosphorylation invokes a catch-22 scenario: on the one hand it requires PP2A-B55
activity; on the other, it promotes B55 reactivation by degrading Cyclin B [216]. It begs the question:
how does initial Cdc20 activation take place? Could a very small pool of B55 have escaped p-ENSA
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inhibition at metaphase to promote Cdc20 dephosphorylation? While this possibility cannot be ruled
out, given the stoichiometric excess of p-ENSA over PP2A-B55 and subnanomolar Kd [101], it is likely
that initial Cdc20 dephosphorylation is commenced by other phosphatases. Kinetochore-localized
PP1-Knl1 was shown to opportunistically dephosphorylate Cdc20 recruited by the ABBA motif within
Bub1 inC. elegans [122]. However, it is likely that other sources of phosphatase activity also target Cdc20,
as abrogation of the PP1 pathway leads to mitotic delay rather than a block. PP2A-B56 represents
another possibility as it is active in mitosis. In fact, PP2A-B56 has been shown to associate with the
APC/C constitutively [123], although the molecular basis of this interaction remains unknown. It has
also been reported that PP2A-B56 promotes the stable association of Ube2S with the APC/C through
dephosphorylation of Cdc20 at Ser92, although the detailed mechanism remains elusive [217].
4.3. Multiple Mechanisms Regulate Degron-Mediated Substrate Degradation
Mitotic exit witnesses degradation of at least a 100 protein substrates in a strict temporal order—a
prerequisite for successful division. Perturbations in this order upset cell division. Coupled with
the fact that protein synthesis exacts a considerable energetic cost, cells have evolved mechanisms to
ensure specific, timely and efficient degradation of substrates by the APC/C. Computational modeling
of APC/C-Cdc20-mediated substrate degradation in yeast concluded that substrate affinity, catalytic
rate of ubiquitin transfer to achieve multi-ubiquitylation and substrate competition can together
determine the order of substrate degradation [218]. Co-activator WD40 domains recruit substrates
by employing structured groves on their surface that bind degron motifs. Degron requirement can
be bypassed by independently recruiting substrates to the E3 ligase by a translational fusion of
a substrate-APC/C subunit for instance [52]. Structural and functional analyses have revealed the three
major degron-binding pockets: D-box (RxxLxxxxN) binds between a conserved region between WD40
blades 1 and 7, while residues C-terminal to it contact the Apc10 co-receptor; KEN box (composed
of residues Lys-Glu-Asn) binding is mediated by the top of the WD40 barrel; and the ABBA motif
(Fx[ILV][FY]x[DE]) receptor is situated within a hydrophobic surface formed between blades 2 and
3 [219–221].
There is considerable plasticity among what constitutes a ‘degron’ motif and seemingly incompatible
residues can be allowed in a particular sequence context. For instance, divergence from consensus
can be tolerated if contacts at additional positions stabilize binding, a concept reviewed by Davey and
Morgan [58]. The degeneracy of the degron binding pocket permits multiple flavors of degrons to bind
likely with a variety of affinities, contributing to their orderly degradation.
Multivalent substrate interactions, either with the WD40 domains by presence of multiple degron
motifs, or with other APC/C subunits can elicit higher affinity—a strategy often employed by APC/C
inhibitors. Higher order properties can also determine substrate binding and degradation. The example
of Nek2A degradation illustrates this concept: the MR tail of Nek2A resembles co-activator and Apc10
IR tails and allows it to be independently bound and degraded by the APC/C during prometaphase,
when the SAC is active. Although necessary, the MR tail is not sufficient for degradation; dimerization
of Nek2A is also essential [222]. It is likely that dimerization works by increasing affinity of Nek2A for
the APC/C, as docking of one molecule by the MR tail would obligatorily bring in a second.
Degron modification is another major mechanism regulating substrate degradation. Acetylation of
BubR1 during metaphase blocks its degradation during metaphase [143]. Additionally, phosphorylation
within and around degron motifs can occasion substrate degradation or stabilization and is highly
context specific. For instance, budding yeast securin phosphorylation on Cdk1 residues situated
outside of the D- and KEN box motifs is refractory to degradation. Activation of the Cdk1-antagonizing
phosphatase Cdc14 by separase leads to securin dephosphorylation and degradation in a positive
feedback loop (as mentioned in Section 3.3) [189]. On the other hand, phosphorylation of human
securin Thr66 that lies within the core of the D-box motif enhances its interaction with the co-activator
and promotes degradation [186,219]. This forms the molecular basis of separase stabilization by its
previously mentioned PP2A-B56 association [186]. Further highlighting the importance of the precise
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position of phosphoresidues in relation to degron motifs are the following examples of Dbf4 and
Cdc6. Phosphorylation of budding yeast DDK kinase subunit Dbf4 one residue after the Arg within its
N-terminal D-box delays its degradation in vivo, indicating that phosphorylation at this position is
inhibitory [210]. Cyclin E-Cdk2 phosphorylates human Cdc6 at two Ser sites, each N-terminal to a D-
and a KEN box and reduces its association with Cdh1 in G1. This blocks Cdc6 degradation to allow
timely origin licensing and S phase initiation [223].
5. Phosphatases Escort Cells through Exit from Mitosis
Phosphostate of a protein is always in flux; it is a readout of the equilibrium kinase and
phosphatase activities governing it. Any change in one of the parameters alters this equilibrium and
is swiftly reflected in the phosphate occupancy of the protein. This is the principle behind rapid
phosphatase activation as cells commence exit from mitosis. Cyclin B degradation by APC/C-Cdc20
decreases Cdk1 activity and creates a domino effect. The balance is shifted towards PP1 autoactivation
by dephosphorylation of its C-terminal tail and I-1 [108–110]. Free PP1 then dephosphorylates
and partially inactivates Greatwall [224–226], ceasing the supply of phosphorylated ENSA/Arpp19.
Any PP2A-B55 dephosphorylated p-ENSA/p-Arpp19 inhibitor molecules are no longer replenished.
Williams et al. estimated that these inhibitors are present in a 5-10 fold excess to PP2A-B55, and
would be dephosphorylated within a few minutes of Greatwall inactivation to swiftly reactivate the
phosphatase [101]. PP2A-B55 completes Greatwall inactivation by full dephosphorylation of the
protein. This positive feedback loop, coupled with the rest of the system architecture makes mitotic
exit a bistable transition [226]. Once liberated, PP2A-B55 is thought to dephosphorylate hundreds of
substrates in conjunction with PP1 and PP2A-B56. In fission yeast, a similar principle of phosphatase
activation governs, although the molecular underpinnings are unclear. PP1 liberated upon Cyclin B
degradation activates PP2A-B55 by directly binding it. Active PP2A-B55 then dephosphorylates a PP1
docking site within PP2A-B56, thereby allowing PP1 to bind and activate it [227]. PP1 could act by
reversing inhibitory B55 phosphorylation mentioned previously [105,106]. How it effects B55- and
B56-bound PP2A enzymes is a question that remains to be answered.
This leads us to an important discussion point: there likely is not one ‘mitotic exit phosphatase’ in
higher organisms. In contrast, inactivation of Cdc14 in budding yeast elicits a complete block and arrests cells
in telophase with elongated spindles due to its role in downregulating kinase activity [213,228,229]. Mitotic
exit in human cells and other vertebrates such as Xenopus has only been prevented upon pan-phosphatase
inhibition by toxins such as okadaic acid (OA) (following Cdk1 inhibition, for instance) [19,230–232], which
inhibits multiple phosphatases to varying degrees. Nonetheless, that phosphatases collaborate to bring
about robust mitotic exit in all organisms is incontrovertible.
Assembly of a central spindle, nuclear envelope reformation, chromosome decondensation and
finally abscission into two daughter cells along the cytokinetic furrow are some of the events associated
with mitotic exit. PP2A-B55 directly dephosphorylates p-Thr481 within Prc1, allowing its association
with the central spindle where it bundles microtubules in an antiparallel array and defines the position
of the cytokinetic furrow. PP2A-B55 also controls dephosphorylation of Aurora A regulator Tpx2 and
its central spindle localization [20]. PP2A-B56 recruited by Kif4a also influences central spindle growth
by opposing Aurora B phosphorylation of Mklp2 and Kif4a [21,233]. PP2A-B56 is also recruited by the
centralspindlin protein Racgap1 and regulates its phosphorylation for accurate execution of cytokinesis.
As mentioned previously, APC/C-Cdh1 activity later degrades Aurora B and halts further signaling.
PP1 also plays a major role in regulating mitotic exit and cytokinesis [234,235]. For instance, PP1 in
conjunction with its regulatory subunit Repo-Man dephosphorylates H3 p-Thr3 to evict Aurora B from
centromeres to the central spindle. Repo-Man association with histones is held in check by inhibitory
phosphorylation by Cdk1. Cyclin B degradation changes the balance of kinase/phosphatase activities
and allows PP1 and PP2A-B56-mediated (via a LxxIxE motif) dephosphorylation of Repo-Man, efficient
PP1 binding and centromere targeting. PP1-Repo-Man has also been implicated in reestablishment of
the nuclear envelope [145,146,236] and dephosphorylation of importin β to initiate nuclear envelope
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reassembly [236]. PNUTS (PP1 Nuclear Targeting Subunit), another PP1 interacting protein binds
chromatin, and has been shown to enhance in vitro chromosome decondensation [237].
This is far from an exhaustive list of phosphatase regulation of mitosis; one can nonetheless
appreciate that it is essential that these events occur in a specific order to avoid mitotic failure.
For instance, premature recruitment of Prc1 to the central spindle upon Greatwall depletion induces
early cytokinesis and causes a ‘cut’ phenotype in a majority of cells [232]. Therefore, not only must
phosphatases be activated at the right time, they must also dephosphorylate hundreds of substrates in
the right order. In Xenopus egg extracts and human cells, high levels of non-degradable Cyclin B block
cells in metaphase, intermediate levels allow progression into a pseudo-anaphase state with separated
sister chromatids, while persistent low levels arrest cells in telophase [238,239]. These observations
suggest that ordering mechanisms exit in higher vertebrates. Differences in PP2A-B55 activation
as a function of Cyclin B levels can partly explain some of these observations [232]. However, once
liberated PP2A-B55 must still contend with a multitude of substrates in the backdrop of opposing
activities of mitotic kinases such as Plk1. In budding yeast, the relative catalytic efficiencies of Cdk1
kinase and Cdc14 phosphatase towards a particular substrate was shown to set its dephosphorylation
time and order mitotic exit [240]. It is likely that similar mechanisms exist in higher organisms, albeit
with different molecular players.
How are hundreds of proteins discriminated by mitotic phosphatases? Part of the answer lies
in intrinsic preference for phosphothreonines exhibited by PP2A phosphatases. Accordingly, survey
of proteins dephosphorylated very early during an induced mitotic exit in human cells revealed that
p-Thr-Pro (p-TP) sites were significantly more dephosphorylated than p-Ser-Pro (p-SP) sites by OA
sensitive phosphatases [19]. A small non-polar residue at the +2 position potentiated, while a +2 Pro
made p-TP refractory to dephosphorylation [19]. In another study of human cells undergoing mitotic
exit as a result of phosphatase activation upon mitotic extract dilution, 45% of candidate PP2A-B55
dependent substrates were p-Thr, compared to 25% p-Thr detected in the total phosphoproteome [20],
corroborating previous observations. Patches of basic residues both N- and C-terminal to the
phosphosite enhanced dephosphorylation and depended on an acidic surface within B55. In fact,
a correlation between motif basophilicity and PP2A-B55 was uncovered [20]. Highly basophilic motifs
would be disfavored by Plk1, perhaps further contributing to their enhanced dephosphorylation [241].
A phosphoproteomic study uncovered that PP6, a phosphatase highly similar to PP2A, instead prefers
acidophilic motifs within substrate proteins and opposes CK2 phosphorylation [242].
A majority of cellular phosphorylation events are catalyzed on serine residues (98.2%) [243].
This could be due to their greater overall numbers in the proteome and higher surface accessibility
compared to the slightly more hydrophobic nature of threonines. How is their dephosphorylation
controlled? Presence of bulky aromatics upstream to the p-Ser enhances their dephosphorylation
by PP2A-B55 and constitutes one mechanism, although its molecular basis is unknown [20]. It is
also possible that, on an average, p-Ser are targeted later in mitosis when p-Thr residues no longer
outcompete them, as substrate competition has been shown to be an ordering mechanism [240].
Finally, it is also likely that a serine-specific phosphatase collaborates with PP2A enzymes. Cdc14
is a p-SPxK/R-directed phosphatase [244,245] and could aid dephosphorylation of some substrates,
particularly in early anaphase. Indeed, human Cdc14B has been shown to catalyze phosphoserine-rich
Cdh1 dephosphorylation upon DNA damage in G2 to induce Plk1 degradation and halt the cell
cycle [246]. Whether a supportive role for Cdc14 in normal mitotic dephosphorylation also exists
remains a question for the future.
Finally, most proteins contain multiple phosphosites that could be potential phosphatase targets
upon binding to substrate docking motifs such as LxxIxE. How the presence of these substrate affinity
elements colludes with phosphosite preferences in the context of the whole protein is unknown.
Our discussion thus far has been simplified by referring to each phosphatase as a homogeneous
entity. This view, however, does the complexity of the system a disservice: each phosphatase has
multiple isoforms. Do they exist to provide redundancy and buffer the system against inactivating
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mutations? Or do they perform distinct functions within the cell? A recent report examined the
importance of multiple B56 isoforms, all of which contain an LxxIxE-binding pocket but exhibit distinct
localizations within cells: while B56α binds Sgo2 at centromeres, B56γ prefers BubR1 binding via
its LxxIxE motif. A small loop within B56α is thought to prevent docking interactions with BubR1
by repressing its binding to LxxIxE motifs, and enabling Sgo2 interactions instead [247]. Specific
binding of PP1γ to its regulatory proteins Repo-Man and Ki-67 follows a similar theme: presence of
an N-terminal Arg residue generates a regulator binding pocket unique to PP1γ [248]. Therefore, there
has been considerable subfunctionalization between different phosphatase isoforms, providing finer
brushstrokes on the canvas of mitosis. Which substrates are targeted by different phosphatase pools
remains unknown. Coupled with structural basis for differential substrate targeting, this knowledge
can aid development of drugs specific to a particular flavor of phosphatase.
6. Roles in Diseases and Avenues for Therapies
As the APC/C and phosphatases have pivotal roles in the cell cycle and beyond, they have been
implicated in various diseases such as cancer. In case of the APC/C, heterozygous mutations within
core subunits Apc3, Apc8 and Apc6 are found in human colon cancer cells [249]. Involvement of the
APC/C co-activators has also been found in tumorigenesis and disease progression. Overexpression of
Cdc20 in particular has been correlated to poor prognosis in various cancers such as non-small cell
lung cancer [250], colorectal cancer [251], multiple myeloma [252], etc. Studies in cancer cell lines
showed that depletion of Cdc20 caused cell cycle arrest and a reduction in cell viability, underlining
active participation of Cdc20 in disease state in addition to its value as a prognostic marker. Further
bolstering the role of Cdc20 as a potential oncogene are observations in mouse skin cancer models,
where inducible depletion of Cdc20 led to regression of tumors due to cell cycle arrest followed by
apoptosis [253]. Cdh1 is thought of as a tumor suppressor, perhaps due to its role in restraining the
entry of cells into the cell cycle and maintaining genome stability. Accordingly, several cancers exhibit
a reduction in Cdh1 levels or function [254–256], due to hyperphosphorylation [257], for instance. Cdh1
heterozygous deletion mice are more susceptible to developing tumors later in life [258]. Furthermore,
Cdh1 also regulates myriad aspects of development and functioning of the nervous system [259], and
its downregulation has been implicated in Alzheimer’s disease [259–261].
APC/C has been proposed as a potential target in cancer therapy, as its inhibition leads to
an arrest in mitosis followed by cell death [262]. Two small molecule inhibitors of the APC/C, TAME
(tosyl-l-arginine methyl ester) and apicin were isolated from screens in Xenopus extracts [263]. TAME
blocks the structurally equivalent C-box and IR binding sites within the APC/C and prevents efficient
co-activator loading [198]. Apicin occludes the D-box receptor within Cdc20 and competes with APC/C
substrates. Simultaneous inhibition of the APC/C with these two inhibitors has a synergistic effect
in blocking mitotic exit [264]—a strategy in clinical use with SAC inhibitors. Indeed, SAC inhibition
alone appears to be inefficient in blocking mitotic exit, as cells escape the arrest due to leaky Cyclin B
degradation [265]. Combination therapy with APC/C inhibition is likely to constitute a more effective
anti-cancer strategy. Additionally, due to the tumor suppressive activity of APC/C-Cdh1, it is desirable
to specifically target APC/C-Cdc20 complexes. It is thus important to understand the differences
between loading of these co-activators.
PP2A has been heavily implicated in several diseases such as cancer, Alzheimer’s disease, diabetes,
etc. [266,267]. Traditionally, PP2A has been thought of as a tumor suppressor, with its downregulation
promoting cancer development. For instance, PP2A subunits have been frequently found to be mutated
in cancer. Cancer-associated mutations within the scaffolding [268,269], catalytic [270] and regulatory
subunits [271] typically tend to affect assembly of the holoenzyme. Endogenous inhibitors of PP2A
such as SET have also been found to be upregulated in cancer cells [272,273], thereby leading to
a reduction in PP2A activity. Following these observations, activation of PP2A has been suggested
as a potential cancer therapy, by inhibiting SET [274], or in combination therapy to prevent PP2A
inhibition-mediated drug resistance [275]. Conversely, PP2A inhibition has been employed to overcome
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resistance of some cancers to radiation therapy [276]. To this end, a small molecule PP2A inhibitor called
LB-100 has entered clinical trials for treatment of solid cancers among others [277]. However, LB-100
also exhibits inhibition of PP5 [278], owing to the previously mentioned similarities in the catalytic
sites of PPP family of phosphatases. Therefore, it is vital to further understand the differences between
phosphatases relevant to diseases to develop specific inhibitors. Targeting PP1 has also been proposed
as an anti-cancer therapy as its inhibition in mouse xenograft models impaired tumor growth [279].
As PP1 binds to hundreds of regulatory proteins, its blanket inhibition is likely to be highly toxic.
Recent drug screening approaches have sought to target specific PP1-regulator holocomplexes in
treatment of Huntington’s disease [280], for instance.
Cell cycle phosphatases have been implicated in numerous signaling pathways, regulating myriad
functions. A systems-level analysis of the consequences of phosphatase perturbation in various
contexts would be a beneficial complement to various studies.
7. Outlook
Mitosis is a tour de force achieved by phosphatases and the APC/C working in concert with
mitotic kinases. They integrate a variety of information to ensure timely and accurate execution of
cell division. Inhibitors, regulatory modifications and opposing activities modulate their activities to
fine-tune passage through cell cycle transitions. The past few years have unfurled layers of regulation
by critical molecular pathways that control their activities.
A larger theme emerging in phosphatase and APC/C function is the ubiquity of regulation by
intrinsically unstructured loop domains. These act as regulatory hubs to occasion myriad effects: they
underlie efficient catalysis by increasing substrate residence time or local concentrations of regulators
with respect to the enzyme. The example of PP1 shows that one enzyme can possess multiple pockets
that bind their own short linear motifs. Thus, it is likely that many other such interactions within other
phosphatase and the APC/C await discovery.
Equilibrium protein modification relies on many factors. Some of them are intrinsic to the substrate,
such as the nature of the phosphosite presented to phosphatases, or indeed the accessibility of the
substrate lysines by the APC/C. These can be further potentiated by the strength of degrons, or presence
of docking motif interactions. However, many factors extrinsic to the substrates are likely to exert
equally important effects on protein modifications. Higher local concentrations of enzymes, achieved by
tethering them to cellular structures for instance, would aid the formation of substrate-enzyme complex
and catalysis. Competition provided by more efficient substrates could also delay enzyme action on
less preferred ones, as would the presence of opposing enzyme activities. Hence, unraveling how these
factors work together would help us better understand how two cells are successfully produced from one.
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